Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment
- PMID: 11735756
- DOI: 10.1001/jama.286.22.2815
Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment
Abstract
Context: Large segments of the population at risk for osteoporosis and fracture have not been evaluated, and the usefulness of peripheral measurements for short-term prediction of fracture risk is uncertain.
Objectives: To describe the occurrence of low bone mineral density (BMD) in postmenopausal women, its risk factors, and fracture incidence during short-term follow-up.
Design: The National Osteoporosis Risk Assessment, a longitudinal observational study initiated September 1997 to March 1999, with approximately 12 months of subsequent follow-up.
Setting and participants: A total of 200 160 ambulatory postmenopausal women aged 50 years or older with no previous osteoporosis diagnosis, derived from 4236 primary care practices in 34 states.
Main outcome measures: Baseline BMD T scores, obtained from peripheral bone densitometry performed at the heel, finger, or forearm; risk factors for low BMD, derived from questionnaire responses; and clinical fracture rates at 12-month follow-up.
Results: Using World Health Organization criteria, 39.6% had osteopenia (T score of -1 to -2.49) and 7.2% had osteoporosis (T score </=-2.5). Age, personal or family history of fracture, Asian or Hispanic heritage, smoking, and cortisone use were associated with significantly increased likelihood of osteoporosis; higher body mass index, African American heritage, estrogen or diuretic use, exercise, and alcohol consumption significantly decreased the likelihood. Among the 163 979 participants with follow-up information, osteoporosis was associated with a fracture rate approximately 4 times that of normal BMD (rate ratio, 4.03; 95% confidence interval [CI], 3.59-4.53) and osteopenia was associated with a 1.8-fold higher rate (95% CI, 1.49-2.18).
Conclusions: Almost half of this population had previously undetected low BMD, including 7% with osteoporosis. Peripheral BMD results were highly predictive of fracture risk. Given the economic and social costs of osteoporotic fractures, strategies to identify and manage osteoporosis in the primary care setting need to be established and implemented.
Comment in
-
Osteoporosis, an underdiagnosed disease.JAMA. 2001 Dec 12;286(22):2865-6. doi: 10.1001/jama.286.22.2865. JAMA. 2001. PMID: 11735763 No abstract available.
-
Identifying fracture risk in postmenopausal women.JAMA. 2002 Mar 6;287(9):1109; author reply 1110. JAMA. 2002. PMID: 11879095 No abstract available.
-
Identifying fracture risk in postmenopausal women.JAMA. 2002 Mar 6;287(9):1109-10. JAMA. 2002. PMID: 11879096 No abstract available.
Similar articles
-
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1. Ont Health Technol Assess Ser. 2006. PMID: 23074491 Free PMC article.
-
The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA).Osteoporos Int. 2006;17(4):565-74. doi: 10.1007/s00198-005-0027-4. Epub 2006 Jan 4. Osteoporos Int. 2006. PMID: 16392027
-
Fracture Rates and Bone Density Among Postmenopausal Veteran and Non-Veteran Women From the Women's Health Initiative.Gerontologist. 2016 Feb;56 Suppl 1(Suppl 1):S78-90. doi: 10.1093/geront/gnv677. Gerontologist. 2016. PMID: 26768394 Free PMC article.
-
Clinical use of bone densitometry: scientific review.JAMA. 2002 Oct 16;288(15):1889-97. doi: 10.1001/jama.288.15.1889. JAMA. 2002. PMID: 12377088 Review.
-
Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.Postgrad Med. 2010 Jan;122(1):82-90. doi: 10.3810/pgm.2010.01.2102. Postgrad Med. 2010. PMID: 20107292 Review.
Cited by
-
Incongruent Treatment Recommendations Between Left and Right Hip Bone Mineral Densities.Cureus. 2024 Sep 22;16(9):e69923. doi: 10.7759/cureus.69923. eCollection 2024 Sep. Cureus. 2024. PMID: 39439642 Free PMC article.
-
Changes in serum runt-related transcription factor 2 levels after a 6-month treatment with recombinant human parathyroid hormone in patients with osteoporosis.J Endocrinol Invest. 2012 Jun;35(6):602-6. doi: 10.3275/8110. Epub 2011 Nov 21. J Endocrinol Invest. 2012. PMID: 22104703
-
Body Composition, Metabolism, and Inflammation in Breast Cancer Survivors and Healthy Age-matched Controls: A Cross-Sectional Analysis.Int J Exerc Sci. 2020 Aug 1;13(3):1108-1119. doi: 10.70252/LSJI9519. eCollection 2020. Int J Exerc Sci. 2020. PMID: 32922634 Free PMC article.
-
Racial/Ethnic Differences in Bone Mineral Density for Osteoporosis.Curr Osteoporos Rep. 2023 Dec;21(6):670-684. doi: 10.1007/s11914-023-00838-y. Epub 2023 Nov 29. Curr Osteoporos Rep. 2023. PMID: 38019343 Review.
-
Relationship between Decrease in Serum Sodium Level and Bone Mineral Density in Osteoporotic Fracture Patients.J Bone Metab. 2015 Feb;22(1):9-15. doi: 10.11005/jbm.2015.22.1.9. Epub 2015 Feb 28. J Bone Metab. 2015. PMID: 25774359 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical